Literature DB >> 10855344

The migraine work and productivity loss questionnaire: concepts and design.

D J Lerner1, B C Amick, S Malspeis, W H Rogers, N C Santanello, W C Gerth, R B Lipton.   

Abstract

Our objectives were to: (1) develop a self-report questionnaire for measuring the impact of migraine headache on work; and (2) qualitatively assess aspects of its performance. Two samples of migraine sufferers provided the data. Sample 1 (n = 18) participated in a structured discussion group designed to elicit examples of migraine's on-the-job impact. Sample 2 (n = 11) completed a mail survey and participated in in-depth phone interviews. Interviews addressed item comprehensibility, consistency of interpretation, the cognitive processes by which certain answers were generated and response burden. The participants were currently employed men and women, at least 18 years of age, who met the International Headache Society (IHS) criteria for migraine headache [1]. Discussion group participants indicated that migraine attacks substantially diminished their job performance. Pain, photophobia, phonophobia, mental impairment and fatigue were perceived as interfering with even routine or relatively simple job tasks. The Migraine Work and Productivity Loss Questionnaire, Version 1.0 (MWPLQ) was written. Next, it was assessed in the context of the in-depth interviews. Result indicated that the MWPLQ was comprehended without difficulty, interpreted consistently and easy to complete. Thus, qualitative results provide initial support for the new questionnaire.

Entities:  

Mesh:

Year:  1999        PMID: 10855344     DOI: 10.1023/a:1008920510098

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  20 in total

1.  The validity and reproducibility of a work productivity and activity impairment instrument.

Authors:  M C Reilly; A S Zbrozek; E M Dukes
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981

Review 2.  Multi-attribute preference functions. Health Utilities Index.

Authors:  G W Torrance; W Furlong; D Feeny; M Boyle
Journal:  Pharmacoeconomics       Date:  1995-06       Impact factor: 4.981

3.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

4.  Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors.

Authors:  W F Stewart; R B Lipton; D D Celentano; M L Reed
Journal:  JAMA       Date:  1992-01-01       Impact factor: 56.272

5.  A survey of migraine in England 1975-1976.

Authors:  J E Green
Journal:  Headache       Date:  1977-05       Impact factor: 5.887

6.  Healthcare resource and lost labour costs of migraine headache in the US.

Authors:  J T Osterhaus; D L Gutterman; J R Plachetka
Journal:  Pharmacoeconomics       Date:  1992-07       Impact factor: 4.981

7.  Study of migraine and the treatment of acute attacks in industry.

Authors:  A Jones; C Harrop
Journal:  J Int Med Res       Date:  1980       Impact factor: 1.671

8.  Impact of sumatriptan on workplace productivity, nonwork activities, and health-related quality of life among hospital employees with migraine.

Authors:  G R Mushet; D Miller; B Clements; G Pait; D L Gutterman
Journal:  Headache       Date:  1996-03       Impact factor: 5.887

9.  Sumatriptan and lost productivity time: a time series analysis of diary data.

Authors:  D W Miller; B C Martin; C M Loo
Journal:  Clin Ther       Date:  1996 Nov-Dec       Impact factor: 3.393

10.  Impact of migraine in the United States: data from the National Health Interview Survey.

Authors:  P E Stang; J T Osterhaus
Journal:  Headache       Date:  1993-01       Impact factor: 5.887

View more
  8 in total

Review 1.  A review of health-related workplace productivity loss instruments.

Authors:  Jennifer H Lofland; Laura Pizzi; Kevin D Frick
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 2.  The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future research.

Authors:  Wayne N Burton; Stephen H Landy; Kristen E Downs; M Chris Runken
Journal:  Mayo Clin Proc       Date:  2009-05       Impact factor: 7.616

Review 3.  The cost and impact of health conditions on presenteeism to employers: a review of the literature.

Authors:  Alyssa B Schultz; Chin-Yu Chen; Dee W Edington
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

4.  The multinational impact of migraine symptoms on healthcare utilisation and work loss.

Authors:  W C Gerth; G W Carides; E J Dasbach; W H Visser; N C Santanello
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 5.  A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective.

Authors:  Manishi Prasad; Peter Wahlqvist; Rich Shikiar; Ya-Chen Tina Shih
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

6.  Symptoms in cervical vertigo.

Authors:  Adam Thompson-Harvey; Timothy C Hain
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-11-28

7.  Early Age of Migraine Onset is Independently Related to Cognitive Decline and Symptoms of Depression Affect Quality of Life.

Authors:  Jiajia Bao; Mengmeng Ma; Shuju Dong; Lijie Gao; Changling Li; Chaohua Cui; Ning Chen; Yang Zhang; Li He
Journal:  Curr Neurovasc Res       Date:  2020       Impact factor: 1.990

8.  Validation of a self-reported instrument to assess work-related difficulties in patients with migraine: the HEADWORK questionnaire.

Authors:  Alberto Raggi; Venusia Covelli; Erika Guastafierro; Matilde Leonardi; Chiara Scaratti; Licia Grazzi; Marco Bartolini; Giovanna Viticchi; Sabina Cevoli; Giulia Pierangeli; Gioacchino Tedeschi; Antonio Russo; Piero Barbanti; Cinzia Aurilia; Carlo Lovati; Luca Giani; Fabio Frediani; Paola Di Fiore; Francesco Bono; Laura Rapisarda; Domenico D'Amico
Journal:  J Headache Pain       Date:  2018-09-10       Impact factor: 7.277

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.